•
Mar 31, 2022

Immix Biopharma Q1 2022 Earnings Report

EPS
-$0.1
Previous year: -$0.3
-66.7%
Cash and Equivalents
$19.1M
Total Assets
$20M

Immix Biopharma

Immix Biopharma